Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy.

Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy.
复制标题

治疗相关的急性非淋巴细胞白血病对强化诱导化疗的反应。

DOI:
10.1002/mpo.2950130410
复制
发表时间:
1985
期刊:
Medical and pediatric oncology
影响因子:
--
通讯作者:
D. Hurd
D. Hurd
中科院分区:
--
文献类型:
--
作者:
S. Duane;B. Peterson;C. Bloomfield;S. Michels;D. Hurd

文献摘要

参考文献

被引文献

相似文献

Among 31 consecutive patients who developed acute nonlymphocytic leukemia following treatment with chemotherapy or radiation therapy, 17 were treated with intensive chemotherapy aimed at inducing a complete remission. Seven of these 17 patients (41%) obtained a complete remission that ranged in duration from 2 to 11 (median 3) months. Two additional patients who failed to develop normal peripheral blood counts despite postinduction bone marrows that were normocellular and free of leukemia were classified as nonresponders. The median time to complete remission and median duration of leukopenia (WBC less than 1,000/mu 1) were 34 days and 23 days, respectively. Induction chemotherapy was complicated by fever in all patients, documented infection in six patients, and death secondary to sepsis in three. Survival of the 17 patients ranged from less than 1 to 39 (median 4) months. Patients achieving a complete remission had a median survival time of 10 months compared to 2 months for the nonresponders. The other 14 patients received only supportive care and had a median survival of 2 months. These findings indicate that therapy-associated acute nonlymphocytic leukemia (t-ANLL) can frequently respond to chemotherapy and that achieving a complete remission is associated with longer survival. Although these results are encouraging, patients with t-ANLL still have a relatively poor prognosis and efforts directed at improving treatment outcome need to be continued.
急性髓系白血病的强化化疗。
DOI: 10.7326/0003-4819-94-6-753
发表时间: 1981
影响因子: 39.2
作者:
Gale,RP;Foon,KA;Cline,MJ;Zighelboim,J
通讯作者: Zighelboim,J
与化疗药物相关的第二种恶性肿瘤。
DOI: --
发表时间: 1982
影响因子: 4
作者:
Kyle,RA
通讯作者: Kyle,RA
阿糖胞苷治疗继发性急性非淋巴细胞白血病。
DOI: 10.1056/nejm198301063080105
发表时间: 1983
期刊: The New England journal of medicine
影响因子: --
作者:
Preisler,HD;Early,AP;Raza,A;Vlahides,G;Marinello,MJ;Stein,AM;Browman,G
通讯作者: Browman,G
霍奇金病治疗后的急性非淋巴细胞白血病。
DOI: 10.1016/0002-9343(83)90348-0
发表时间: 1983
期刊: The American journal of medicine
影响因子: --
作者:
Aisenberg,AC
通讯作者: Aisenberg,AC